万邦医药：2026年第一次临时股东会决议公告
Anhui Wanbang Pharmaceutical Technology Anhui Wanbang Pharmaceutical Technology (SZ:301520) Zheng Quan Ri Bao·2026-01-14 14:23

Group 1 - The core point of the article is that Wanbang Medical announced the approval of a proposal to use part of its idle raised funds (including over-raised funds) and self-owned funds for cash management at its first extraordinary shareholders' meeting in 2026 [2]